Vaknin-Dembinsky A - Search Results

1

The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells.

Zveik O, Rechtman A, Ganz T, Vaknin-Dembinsky A. Zveik O, et al. Among authors: vaknin dembinsky a. Mol Neurodegener. 2024 Jul 12;19(1):53. doi: 10.1186/s13024-024-00742-8. Mol Neurodegener. 2024. PMID: 38997755 Free PMC article. Review.

2

Pediatric demyelinating diseases: multiple sclerosis or not?

Vaknin-Dembinsky A, Karussis D. Vaknin-Dembinsky A, et al. Isr Med Assoc J. 2012 Apr;14(4):251-3. Isr Med Assoc J. 2012. PMID: 22675845 Free article. No abstract available.

3

Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS.

Vaknin-Dembinsky A, Brass SD, Gandhi R, Weiner HL. Vaknin-Dembinsky A, et al. J Neuroimmunol. 2008 Mar;195(1-2):135-9. doi: 10.1016/j.jneuroim.2008.01.016. Epub 2008 Apr 1. J Neuroimmunol. 2008. PMID: 18378324 Free PMC article.

4

Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis.

Vaknin-Dembinsky A, Murugaiyan G, Hafler DA, Astier AL, Weiner HL. Vaknin-Dembinsky A, et al. J Neuroimmunol. 2008 Mar;195(1-2):140-5. doi: 10.1016/j.jneuroim.2008.01.002. Epub 2008 Apr 10. J Neuroimmunol. 2008. PMID: 18403025 Free PMC article.

5

MIF -173G/C polymorphism is associated with NMO disease severity.

Brill L, Vaknin-Dembinsky A, Zveik O, Haham N, Miller K, Benedek G. Brill L, et al. J Neuroimmunol. 2020 Feb 15;339:577120. doi: 10.1016/j.jneuroim.2019.577120. Epub 2019 Nov 25. J Neuroimmunol. 2020. PMID: 31790982

6

Brain MRI activity during the year before pregnancy can predict post-partum clinical relapses.

Lehmann H, Zveik O, Levin N, Brill L, Imbar T, Vaknin-Dembinsky A. Lehmann H, et al. Mult Scler. 2021 Dec;27(14):2232-2239. doi: 10.1177/13524585211002719. Epub 2021 Mar 30. Mult Scler. 2021. PMID: 33783260

7

Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab.

Brill L, Rechtman A, Zveik O, Haham N, Oiknine-Djian E, Wolf DG, Levin N, Raposo C, Vaknin-Dembinsky A. Brill L, et al. JAMA Neurol. 2021 Dec 1;78(12):1510-1514. doi: 10.1001/jamaneurol.2021.3599. JAMA Neurol. 2021. PMID: 34554197 Free PMC article.

8

Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis.

Brill L, Rechtman A, Zveik O, Haham N, Levin N, Shifrin A, Rozenberg A, Vaknin-Dembinsky A. Brill L, et al. Mult Scler Relat Disord. 2022 Jan;57:103343. doi: 10.1016/j.msard.2021.103343. Epub 2021 Oct 23. Mult Scler Relat Disord. 2022. PMID: 35158452 Free PMC article.

9

Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab.

Brill L, Raposo C, Rechtman A, Zveik O, Levin N, Oiknine-Djian E, Wolf DG, Vaknin-Dembinsky A. Brill L, et al. Ann Neurol. 2022 Jun;91(6):796-800. doi: 10.1002/ana.26343. Epub 2022 Mar 24. Ann Neurol. 2022. PMID: 35243687 Free PMC article.

10

Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells.

Zveik O, Fainstein N, Rechtman A, Haham N, Ganz T, Lavon I, Brill L, Vaknin-Dembinsky A. Zveik O, et al. Glia. 2022 Jun;70(6):1191-1209. doi: 10.1002/glia.24165. Epub 2022 Mar 9. Glia. 2022. PMID: 35266197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters